Why the study?
Does a prediction model based on clinical and demographic information reliably identify patients at high risk of recurrent major vascular events after a recent TIA or nondisabling stroke?
Population
3,127 patients within 3 months after onset of a transient ischemic attack, amaurosis fugax, or nondisabling…
Design
Cohort, double-blind (in the original trial)
Authors
Loading...
Insufficient clinical-demographic models limit reliable high-risk identification post-TIA; leaves open integration of novel biomarkers for better stratification.
Does a prediction model based on clinical and demographic information reliably identify patients at high risk of recurrent major vascular events after a recent TIA or nondisabling stroke?
Existing clinical and demographic prognostic factors are insufficient to reliably identify patients at high risk of recurrent major vascular events after a TIA or nondisabling stroke.
Dippel et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: